Ansem Responds to "Creator Coin" Controversy: Commits to Long-term Vision, Cites Dogecoin and BONK as Examples
BlockBeats News, June 30th - Crypto KOL Ansem responded to the recent trend of "Creator Coins," acknowledging the controversy it has sparked. He admitted that he was previously cautious about celebrities issuing coins because he wrongly assumed that they would share the same moral standards as him and would not rug-pull for millions of dollars. He stated, "This assumption was wrong, but I will not make the same mistake again," emphasizing that he is not a celebrity and has no rug-pull plans.
Ansem expressed his belief in a way of issuing coins that benefits everyone: attracting new users to the crypto industry, allowing people to participate through speculative assets, providing liquidity for "old rugs" at the bottom of a bear market, and then redirecting the attention gained to truly meaningful projects and teams in the industry. He cited Dogecoin and BONK as examples— the former started from 0 and now has a market capitalization of $110 billion, marking a significant user acquisition event in the crypto industry; the latter revitalized the Solana ecosystem at the market's lowest point during the FTX meltdown and airdropped tokens to core developers and teams.
Ansem also revealed that he entered the industry in 2017, quit his software engineering job in 2021 to fully devote himself to the crypto field, co-founded the trading application Bullpen.fi, and runs a podcast. He stressed that this was the first project he led and controlled the majority of the token's supply, as several "degen coins" he had previously supported experienced "rug-pulls" due to anonymous teams hoarding coins in advance and using his influence to hype up the projects.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request
A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.
After years of waiting and another delay, Tesla (TSLA.US) postpones the Roadster debut to October 15 as severe weather forces the event to stop.
Tesla has rescheduled the unveiling event for its next-generation Roadster, originally planned for this week, to October 15.
Debt and inflation become the biggest constraints! Deutsche Bank warns: The global market "policy safety net" is failing and future volatility may intensify
Deutsche Bank Research stated in its latest report that the era of large-scale policy interventions used to cushion global economic shocks over the past decades is coming to an end. The continuous rise in sovereign debt, high interest rates, and persistent inflation are all weakening the traditional “safety net” relied upon by governments and central banks.
Bellock executive Lee Young Hoon lifts stake to 0.99% from 0.56%
